Global Cardiopulmonary Devices Market valued at $2.8 billion in 2021, is expected to witness a growth of 5% by 2026

Cardiopulmonary diseases include a range of medical conditions that affect the heart and lungs. Cardiopulmonary devices include heart-lung machines (HLM), percutaneous ventricular assist devices (PVAD), extracorporeal membrane oxygenation (ECMO) & Autotransfusion (ATS). These devices find usage in cardiac surgeries, pulmonary surgeries, congenital defects, cardiopulmonary bypass procedures, cardiogenic shock/respiratory failure, joint replacement surgeries, aneurysm surgeries, transplants, and other indications.

Impact of Covid-19 Pandemic on the Cardiopulmonary Devices Market

During 2020-2021, most of the patients infected with the Covid-19 virus showcased moderate symptoms and recovered quickly. However, some patients developed severe respiratory failure and required intensive care unit (ICU) admission and mechanical ventilation. To treat and save the lives of these severe Covid-19 patients, ECMO emerged as a promising treatment option. The ECMO machine supports both the heart and lungs and stabilizes patients to allow their bodies more time to fight the virus.

Regulatory Policies in Major Markets Boosts the Cardiopulmonary Devices Market

To fight the Covid-19 pandemic and to offer cardiopulmonary and advanced circulatory support products and therapies that may benefit Covid-19 virus-infected patients, in April 2020 the FDA permitted manufacturers of cardiopulmonary bypass devices to modify the product indications for use to include ECMO therapy for greater than six hours, without prior submission of a premarket notification to FDA. The favourable regulatory policy change resulted in increased sales of cardiopulmonary and advanced circulatory support products.

“ECMO has emerged as a game-changer for Covid-19 patients. It has proven to be a life saver. More than 200 patients at our hospital who have been on ECMO longer than 24 hours have recovered.”-Director, Mechanical Circulatory Support & ECMO, Leading Hospital, United States

Technological Advancements Drives the Cardiopulmonary Devices Market

The cardiopulmonary devices market is a technology-driven market and is marked by constant product enhancements/innovations. For instance,

  • In April, 2022, LivaNova initiates the targeted commercial launch of the Essenz™ Patient Monitor for cardiopulmonary bypass procedures. The transformative monitoring system uses a patient-tailored approach to improve clinical efficiency and quality of patient care during cardiopulmonary bypass (CPB) procedures.

Growth Strategies Adopted by Key Players to Establish Their Foothold in Cardiopulmonary Devices Market

The global cardiopulmonary devices market is marked by the presence of both established and new players. Players operating in the market have adopted both organic and inorganic growth strategies such as acquisitions, and new product launches to garner higher market share. For instance,

  • In February 2022, Getinge acquired 100% of the equity interest in Talis Clinical LLC, a US-based leading innovator of High Acuity cloud-based software solutions. Talis Clinical’s offer is designed to support and document care throughout the general and cardiac perioperative care process, but also through labor and delivery episodes and critical care support including ECMO Therapy.

The cardiopulmonary devices market is estimated to grow at a decent rate in the upcoming years due to growing cases of cardiopulmonary cases, technological advancements in cardiopulmonary devices, rising number of orthopaedic & transplant procedures, and rising aging population.

Competitive Landscape Analysis: Cardiopulmonary Devices Market

The cardiopulmonary devices market is marked by the presence of major market players such as LivaNova, Getinge, Terumo, Medtronic, Abbott, Abiomed, Haemonetics, Fresenius, among others.

Get Customized Research Report on Cardiopulmonary Devices Market @ https://meditechinsights.com/cardiopulmonary-devices-market/

Comments

Post a Comment

Popular posts from this blog

Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transforms into precancerous cells. If not destroyed, these abnormal cells may turn into harmful cancer cells and spread in the cervix and surrounding areas. Cervical cancer screening involves HPV and PAP tests , which can identify HPV infection or pre-cancerous lesions at an early stage and if correct treatment is offered at the right time then the cancer can be prevented. Impact of  Covid-19 on  the Global HPV Testing and PAP Test Market Covid-19 pandemic had impacted the healthcare market in many ways. During Covid pandemic, due to strict social-distancing norms in hospitals, there was a delay in many diagnostic examinations and procedures. The delay in the cancer screening services due to the lack of skilled healthcare staff and disruption in the supply chain of testing kits across the world had led to a severe impact o
Read more

Global Medical Display Market is projected to witness a CAGR of 5% by 2027 - Transforming Medical Imaging

Medical displays are purpose-built solutions which offer quick improvements in viewing angle, longevity, luminance, and noise reduction to assure substantially superior accuracy and effectiveness of medical images. Technological Developments and Innovations in Medical Display Drives the Growth of the Global Medical Display Market With the rapid innovations and developments in medical technology, many high-end medical equipment's are being introduced in the global market. Flat-panel displays, holograms, and head-mounted displays are quickly changing the manner in which medical messages are being communicated. The majority of displays used for medical imaging are liquid crystal displays (LCDs) backlit with either CCFLs or LEDs.  For instance,  In January 2023, Barco announced the release of a new LED solution which completes its next-generation LED portfolio. Adoption of Multimodality Display Fuels the Global Growth of the Medical Display Market  With the fast evolution of the medi
Read more

Global Ambulatory Surgical Center (ASC) Software Market is Poised to Grow at a CAGR of 10% by 2027

Ambulatory Surgical Care is a medical care offered in the outpatient setting and does not need any hospital admission. Ambulatory Surgical Center or ASCs—are health care facilities focused on offering same-day surgical care, including diagnostic and preventive procedures. ASCs have transformed the outpatient experience by offering a convenient alternative to hospital-based outpatient procedures. Common procedures performed in ASCs are cataract surgery, gallbladder removal, tonsillectomy, endoscopy, colonoscopy, arthroscopic or orthopedic procedures, and cardiac procedures. Owing to their various cost benefits and convenience, the volume of procedures performed at ASCs is rising and ASC software is likely to play a major role in these settings by easing the day to day operations by preparing staff and patients for pre-op and post-op tasks. Rising Investments in Ambulatory Surgical Center  from Healthcare Companies Shows a Huge Growth Potential for Ambulatory Surgical Center Software Ma
Read more